Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 5:56 PM
Ignite Modification Date:
2025-12-24 @ 5:56 PM
NCT ID:
NCT03727568
Eligibility Criteria:
Inclusion Criteria:
* Inpatients with suspected ILD based on clinical and radiological features
* Male or female patients aged ≥18 years
* Signed the informed consent
* Clinical indication to performed a lung biopsy in radiologically proven ILD
Exclusion Criteria:
* Bleeding risk:
* Known predisposition to bleeding
* International randomised ratio (INR) \>1,5,
* Elevated partial thromboplastin time (PTT)
* Platelet count \< 80000/ul
* Patients who required full-dose therapeutic anticoagulation or clopidogrel or other thienopyridines
* Oxygen saturation \< 90% with supported Oxygen 2l/min
* Severe bullous pulmonary emphysema
* Severe cardiac disease (angina pectoris, acute myocardial infarction in the last 6 month, acute hearth failure)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT03727568
Study Brief:
Protocol Section:
NCT03727568